|
KMID : 1207720190110020233
|
|
Clinics in Orthopedic Surgery
2019 Volume.11 No. 2 p.233 ~ p.236
|
|
|
Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors
|
|
Chung Hak-Sun
Kim Sang-Hyo
Chung So-Hak
|
|
|
Abstract
|
|
|
Background: We investigated the clinical outcome in patients whose cavitary bone defects were treated with beta-tricalcium phosphate (β-TCP) after surgical removal of benign tumors.
Methods: Between March 2015 and December 2015, 20 patients who underwent operation for bone tumors were enrolled into this study and prospectively followed up for a median period of 28.1 months.
Results: When the radiographic sign of complete resorption was defined as greater than 50% resorption of the allograft material accompanied by bone remodeling until 12 months, 55% of patients had complete resorption. Positive correlation between the filling volume and time needed for complete resorption was not found (p = 0.184).
Conclusions: Purified β-TCP could be a suitable choice as a bone graft substitute after the removal of benign bone tumors.
|
|
|
KEYWORD
|
|
|
Beta-tricalcium phosphate, Bone transplantation
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|